PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 42713222

Translating evidence into practice: Developing Canada's first position statement on genomics-informed oncology nursing.

Andrea Gretchev·Rebecca Puddester·Patrick Chiu·Lindsay Carlsson·Kathleen Leslie·Catriona Buick·April Pike·Jacqueline Limoges
View original source ↗Export metadata ↓

Abstract

The integration of genomics in oncology care is accelerating in Canada, presenting new opportunities for nurses to improve cancer outcomes through enhanced screening, diagnosis, and targeted therapies. However, nurses have identified that they require policy guidance to clarify their roles and responsibilities as members of interprofessional teams delivering genomic services. In response, the Canadian Nursing and Genomics Initiative, in collaboration with the Canadian Association of Nursing in Oncology/Association Canadienne des Infirmières et Infirmiers en Oncologie, and an interdisciplinary working group developed the first pan-Canadian position statement to guide genomics-informed oncology nursing practice. To support further engagement and use of the position statement, we outline the rationale for developing the position statement and the role of position statements in supporting nursing practice and innovation in genomics-informed oncology nursing. We describe the governance structure and co-design methodology that facilitated its collaborative interdisciplinary development, and how this approach is critical for nursing advocacy, integrated knowledge translation, and ongoing engagement. Finally, we offer recommendations for oncology nurses to translate the position statement into practice changes. This position statement is a preliminary step toward advancing genomics integration in cancer care and ensuring nursing practice remains at the forefront of innovation.

Explore related subjects

geneticsgenomic literacygenomicsnursingpolicyworkforce developmentJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Andrea Gretchev, Rebecca Puddester, Patrick Chiu, Lindsay Carlsson, Kathleen Leslie, Catriona Buick, April Pike, Jacqueline Limoges. 2026-01-01. Translating evidence into practice: Developing Canada's first position statement on genomics-informed oncology nursing.. https://doi.org/10.5737/2368807636166

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2025

Non-HLA Genetics and Application to Living Donor Candidates.

PURPOSE OF REVIEW: This review examines the expanding role of non-human leukocyte antigen (non-HLA) genetic factors in kidney transplantation, with a particular focus on their implications for living donor evaluation and outcomes. It emphasizes the potential of genetic testing to improve risk stratification beyond conventional HLA matching, especially for donor candidates with a family history of hereditary kidney disease. RECENT FINDINGS: Non-HLA genetic mismatches, including single nucleotide variants affecting minor histocompatibility antigens, can drive alloimmune responses, leading to graft rejection and failure even in HLA-matched transplants. The presence of non-HLA antibodies further contributes to adverse immunological outcomes. Genetic testing in related living donors can uncover monogenic kidney diseases, enabling early identification of at-risk individuals and enhancing donor safety. While polygenic risk scores and gene panels show promise in predicting complications and guiding post-transplant care, most genome-wide association studies have focused on recipients. There remains a significant gap in understanding how donor-specific genetic factors influence post-donation kidney function and long-term health outcomes. SUMMARY: The integration of non-HLA genetic testing into living donor evaluation supports a precision medicine approach to kidney transplantation, offering improved risk assessment and donor-recipient matching. As the field advances, longitudinal studies and robust data collection, particularly around donor genetics, are essential to optimize transplant outcomes, inform clinical decision-making, and uphold ethical standards in donor care.

genetics↗